Pheochromocytoma Global Clinical Trials Review, H1, 2018

Pheochromocytoma Global Clinical Trials Review, H1, 2018


  • Products Id :- GDHC4977CTIDB
  • |
  • Pages: 67
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pheochromocytoma Global Clinical Trials Review, H1, 2018

 

Summary

 

GlobalData's clinical trial report, Pheochromocytoma Global Clinical Trials Review, H1, 2018 provides an overview of Pheochromocytoma clinical trials scenario. This report provides top line data relating to the clinical trials on Pheochromocytoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

 

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

 

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

 

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Reasons to buy

 

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

 

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Clinical Trials by G7 Countries: Proportion of Pheochromocytoma to Oncology Clinical Trials 14

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Pheochromocytoma to Oncology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Pheochromocytoma Therapeutics Clinical Trials 29

Prominent Drugs 31

Latest Clinical Trials News on Pheochromocytoma 32

Mar 19, 2018: Progenics Pharmaceuticals Announces Presentation of AZEDRA (iobenguane I 131) Biochemical Tumor Marker Data at the 2018 Endocrine Society Annual Meeting 32

Clinical Trial Profile Snapshots 33

Appendix 76

Abbreviations 76

Definitions 76

Research Methodology 77

Secondary Research 77

About GlobalData 78

Contact Us 78

Disclaimer 78

Source 79

List of Figures

Pheochromocytoma Therapeutics, Global, Clinical Trials by Region (%), 2018* 8

Pheochromocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

Pheochromocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 11

Pheochromocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 12

Pheochromocytoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 13

Pheochromocytoma Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 14

Proportion of Pheochromocytoma to Oncology Clinical Trials, G7 Countries (%), 2018* 15

Pheochromocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Pheochromocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18

Proportion of Pheochromocytoma to Oncology Clinical Trials, E7 Countries (%), 2018* 19

Pheochromocytoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20

Pheochromocytoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21

Pheochromocytoma Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22

Pheochromocytoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 23

Pheochromocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24

Pheochromocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25

Pheochromocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26

Pheochromocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 27

Pheochromocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28

Pheochromocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30

Pheochromocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 32

GlobalData Methodology 78

List of Tables

Pheochromocytoma Therapeutics, Global, Clinical Trials by Region, 2018* 8

Pheochromocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

Pheochromocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 11

Pheochromocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 12

Pheochromocytoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 13

Pheochromocytoma Therapeutics Clinical Trials, North America, Top Countries, 2018* 14

Proportion of Pheochromocytoma to Oncology Clinical Trials, G7 Countries (%), 2018* 15

Pheochromocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Pheochromocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18

Proportion of Pheochromocytoma to Oncology Clinical Trials, E7 Countries (%), 2018* 19

Pheochromocytoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20

Pheochromocytoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21

Pheochromocytoma Therapeutics, Global, Clinical Trials by Phase, 2018* 22

Pheochromocytoma Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 23

Pheochromocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24

Pheochromocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25

Pheochromocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26

Pheochromocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 27

Pheochromocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28

Pheochromocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30

Pheochromocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 32

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Progenics Pharmaceuticals IncPfizer IncOno Pharmaceutical Co LtdMolecular Insight Pharmaceuticals IncExelixis IncEndo International PlcEisai Co LtdBristol-Myers Squibb CoAstraZeneca PlcAbbVie Inc

Pheochromocytoma Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CROs, Terminated, Suspended and Withdrawn trials of Pheochromocytoma, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania

select a license
Single User License
USD 2500 INR 179600
Site License
USD 5000 INR 359200
Corporate User License
USD 7500 INR 538800

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com